Skip to content

Your donation DOUBLED through April 30 thanks to anonymous donors who pledged to match your gift!   DONATE NOW!

Clinician Experience with Genetic Testing of Ataxia Patients

Clinician Experience with Genetic Testing of Ataxia Patients

The goal of this study is to assess clinician experiences of genetic testing of patients with ataxia, specifically to understand ordering patterns and perceptions on utility of testing.

Link to Survey: https://forms.office.com/r/wvbn0zm6Hi

About the Study

Eligible Ataxia Types
Ataxia Clinicians

Type of Study
Survey

Clinical Trial Phase
N/A

Age Range
Adult 18+

Study Start Date
08/20/2024

Estimated Completion Date
07/30/2025

IRB Approval #
HUM00255285

Location(s)

Virtual Study

Contact Information

Sharan Srinivasan
sharans@med.umich.edu
734-615-8116

What does participation in the study entail?

Completion of a one-time survey. This survey only asks about type of provider (neurologist, specialist, GC) and country of practice. No other identifying information is requested.

What are the potential benefits for participants?

The results of this survey will allow participants to understand both testing patterns amongst colleagues around the world, as well as to reflect on the perceived utility of genetic testing.

What are the potential risks for participants?

There is no predicted risk for participants as no intervention is being performed.

Is there financial compensation?

No.

Is there travel reimbursement?

Not applicable.

Who is eligible?

All providers, including genetic counselors, ataxia neurologists, general neurologists, and other physicians, provided they are actively involved in the genetic counseling and/or testing of patients with ataxia.

Additional Information or Resources

Link to complete survey: https://forms.office.com/r/wvbn0zm6Hi

View Other Research Opportunities

The goal of this study is to assess clinician experiences of genetic testing of patients with ataxia, specifically to understand ordering patterns and perceptions on utility of testing.

Link to Survey: https://forms.office.com/r/wvbn0zm6Hi

About the Study

Eligible Ataxia Types
Ataxia Clinicians

Type of Study
Survey

Clinical Trial Phase
N/A

Age Range
Adult 18+

Study Start Date
08/20/2024

Estimated Completion Date
07/30/2025

IRB Approval #
HUM00255285

Location(s)

Virtual Study

Contact Information

Sharan Srinivasan
sharans@med.umich.edu
734-615-8116

What does participation in the study entail?

Completion of a one-time survey. This survey only asks about type of provider (neurologist, specialist, GC) and country of practice. No other identifying information is requested.

What are the potential benefits for participants?

The results of this survey will allow participants to understand both testing patterns amongst colleagues around the world, as well as to reflect on the perceived utility of genetic testing.

What are the potential risks for participants?

There is no predicted risk for participants as no intervention is being performed.

Is there financial compensation?

No.

Is there travel reimbursement?

Not applicable.

Who is eligible?

All providers, including genetic counselors, ataxia neurologists, general neurologists, and other physicians, provided they are actively involved in the genetic counseling and/or testing of patients with ataxia.

Additional Information or Resources

Link to complete survey: https://forms.office.com/r/wvbn0zm6Hi

View Other Research Opportunities

Print Friendly, PDF & Email
Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.